First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience

By Olsen Ingrid Holst   Langer Seppo W.   Jepsen Ida   Assens Maria   Federspiel Birgitte   Hasselby Jane Preuss   Hansen Carsten Palnæs   Kjær Andreas   Knigge Ulrich  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of nimotuzumab plus gemcitabine usage as first-line treatment in patients with advanced pancreatic cancer

By Su Dan   Jiao Shun-Chang   Wang Li-Jie   Shi Wei-Wei   Long Yan-Yan   Li Juan   Bai Li  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2313-2318

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study - docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

By Rougier P.   Adenis A.   Ducreux M.   de Forni M.   Bonneterre J.   Dembak M.   Clouet P.   Lebecq A.   Baille P.   Lefresne-Soulas F.   Blanc C.   Armand J.P.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 1016-1025

Elsevier

Access to resources Recommend Favorite

Transient partial response of poorly-differentiated thyroid carcinoma to sunitinib treatment: A case report

By            

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 492-496

Spandidos Publications

Access to resources Recommend Favorite

Sunitinib malate

By Izzedine Hassane   Buhaescu Irina   Rixe Olivier   Deray Gilbert  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 357-364

Springer Publishing Company

Access to resources Recommend Favorite